Current Development of Nano-Drug Delivery to Target Macrophages
Macrophages are the most important innate immune cells that participate in various inflammation-related diseases. Therefore, macrophage-related pathological processes are essential targets in the diagnosis and treatment of diseases. Since nanoparticles (NPs) can be preferentially taken up by macroph...
Main Authors: | Donglin Cai, Wendong Gao, Zhelun Li, Yufeng Zhang, Lan Xiao, Yin Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/5/1203 |
Similar Items
-
Antitumor therapy for breast cancer: Focus on tumor‐associated macrophages and nanosized drug delivery systems
by: Cuiping Zhan, et al.
Published: (2023-05-01) -
PLGA Based Nanospheres as a Potent Macrophage-Specific Drug Delivery System
by: Barbora Boltnarova, et al.
Published: (2021-03-01) -
Recent advances in macrophage-targeted nanoparticle drug delivery platforms for treating synovitis in rheumatoid arthritis
by: Hu Wanhua, Xu Yizhou, Bai Zhenglin, Wang Zeyu
Published: (2024-02-01) -
Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment
by: Yuesong Wu, et al.
Published: (2022-12-01) -
The Development of Hyaluronan/Fucoidan-Based Nanoparticles as Macrophages Targeting an Epigallocatechin-3-Gallate Delivery System
by: Chang-Hsun Ho, et al.
Published: (2020-08-01)